Summary
In an observer-blind, randomised cross-over trial, in 12 patients, the effects on the peripheral circulation of antihypertensive doses of atenolol, labetalol and propranolol and placebo were compared. After a placebo period of at least 4 weeks, patients were allocated at random to one of the three active drug treatments. After active treatment for at least 6 weeks and a fall in diastolic pressure (DP) to less than 90 mmHg subjects were switched to the next medication. At the end of each period, photoelectric plethysmography (PHELP) was done on all fingers of one hand cooled over 4 min in water in steps of 3°C from 33° to 12°C, and subsequently warmed in room air (20°C) for a period of 10 min. Blood flow changes during cooling were expressed as a percentage of the initial PHELP value (% PHELP). Areas under the curves, representing the % PHELP/cooling period and % PHELP/warming-up period, showed that within the temperature range normally encountered in daily life, labetalol preserved finger blood flow significantly better than propranolol and marginally better than placebo. With atenolol, finger blood flow was not significantly different from that during the three other regimens, but there were significantly fewer other side-effects. It is concluded that labetalol may be the drug of choice for hypertensive patients treated with beta-blocking agents whose peripheral arterial circulation seems inadequate at low temperatures.
Similar content being viewed by others
References
Brittain RI, Levy GP (1976) A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor blocking drug. Br J Clin Pharmacol [Suppl] 3: 681–694
Cruickshank JM, Neil-Dwyer G, Cameron MM, Mc Ainsh J (1980) Beta-adrenoreceptor blocking agents and the blood-brain barrier. Clin Sci 59: 453s-455s
Frohlich ED, Larazi RC, Dustan HP (1969) Peripheral arterial insufficiency: a complication of beta adrenergic blocking therapy. J Am Med Assoc 208: 2471–2472
Heck I, Trübestein G, Stumpe KO (1981) Effects of combined α-and β-receptor blockade on peripheral circulation in essential hypertension. Clin Sci 61: 429–432
Ireland MA, Littler WA (1981) The effects of oral acebutolol and propranolol on forearm blood flow in hypertensive patients. Br J Clin Pharmacol 12: 363–368
Marshall AJ, Roberts CJC, Barrit DW (1976) Raynaud's phenomenon as side effect of β-blockers in hypertension. Br Med J 1: 1498–1499
Ohlsson O, Lindell S-E (1981) The effects of pindolol and prazosin on hand blood flow in patients with cold extremities and on treatment with β-blockers. Acta Med Scand 210: 217–219
de Pater L, van der Berg JW, Bueno AA (1962) A very sensitive photoplethysmograph using scattered light and a photosensitive resistance. Acta Physiol Pharmacol Neerl 10: 378–390
Simpson FO (1974) β-adrenergic receptor blocking drugs in hypertension. Drugs 7: 85–105
Steiner JA, Cooper R, Gear JS, Ledingham JGG (1979) Vascular symptoms in patients with primary Renaud's phenomenon are not exacerbated by propranolol or labetalol. Br J Clin Pharmacol 7: 401–403
Waal-Manning HJ (1976) Hypertension: which beta-blocker? Drugs 12: 412–441
Wesseling H, den Heeten A, Wouda AA (1981) Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon. Eur J Clin Pharmacol 20: 329–333
Wilcox RG (1980) Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J 280: 885–888
Wouda AA (1977) Raynaud's phenomenon. Acta Med Scand 201: 519–523
Zacharias FJ (1976) Patient acceptability of propranolol and the occurrence of side-effects. Postgrad Med J 52: 87–89
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Veur, E., ten Berge, B.S., Wouda, A.A. et al. Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease. Eur J Clin Pharmacol 28, 131–134 (1985). https://doi.org/10.1007/BF00609679
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609679